Yan, Foster City
Guoyi Yan, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20150319138 | FILTERING HIDDEN DATA EMBEDDED IN MEDIA FILES - Systems and methods for filtering unsafe content at a network security appliance are provided. According to one embodiment, a network security appliance captures network traffic and extracts a media file from the network traffic. The network security appliance then determines the presence of a hidden data item embedded in the media file in a machine-readable form. When such a hidden data item is identified, the network security appliance performs one or more actions on the media file based on a predefined security policy. | 11-05-2015 |
Minhong Yan, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20090214564 | ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME - The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies. | 08-27-2009 |
20100015135 | ANTI-EPHB4 ANTIBODIES AND METHODS USING SAME - The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies. | 01-21-2010 |
20100129356 | COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT - The present invention provides methods of using a DLL4 modulator to modulate vascular development. Furthermore, methods of treatment using DLL4 modulators, such as DLL4 antagonists, are provided. | 05-27-2010 |
20100292312 | ANTI-DLL4 ANTIBODIES AND METHODS USING SAME - The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies. | 11-18-2010 |
20120171203 | ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE - Disclosed herein are methods and compositions for treating disorders associated with angiogenesis or lymphangiogenesis using ALK-1 antagonists. | 07-05-2012 |
20120207747 | ANTI-EPHB4 ANTIBODIES AND METHODS USING SAME - The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies. | 08-16-2012 |
20130143266 | ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME - The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies. | 06-06-2013 |
20150250874 | ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE - Disclosed herein are methods and compositions for treating disorders associated with angiogenesis or lymphangiogenesis using ALK-1 antagonists. | 09-10-2015 |
Xuelei Yan, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20090176768 | DIAZA HETEROCYCLIC AMIDE COMPOUNDS AND THEIR USES - Diaza heterocyclic amide derivatives according to Formula (I) have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: | 07-09-2009 |
20100069447 | BENZAMIDE DERIVATIVES AND USES RELATED THERETO - Benzamide derivatives of formulae I and II, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof, and pharmaceutical compositions comprising the same, are described and have therapeutic utility, particularly in the treatment of diabetes, obesity, and related conditions and disorders: | 03-18-2010 |
20100280073 | TRICYCLIC INHIBITORS OF HYDROXYSTEROID DEHYDROGENASES - The present invention provides tricyclic compounds according to formula (I): (I) where R | 11-04-2010 |
20110319378 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 12-29-2011 |
20140235629 | HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I or II, or the pharmaceutically acceptable salts thereof, | 08-21-2014 |
20140315895 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 10-23-2014 |